R Flisiak, M Pawłowska, M Rogalska-Płońska… - Vaccines, 2021 - mdpi.com
The current study aimed to determine to what extent prior COVID-19 infection affects the response of specific antibodies following vaccination. The study involved 173 healthcare …
N Lee, S Jeong, SK Lee, EJ Cho, J Hyun, MJ Park… - Vaccines, 2022 - mdpi.com
We quantitatively analyzed SARS-CoV-2 antibody levels in patients after two doses of the ChAdOx1 nCoV-19 vaccine and the third BNT162b2 booster. We obtained 255 serum …
YK Kim, D Minn, SH Chang, JS Suh - Vaccines, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) vaccination began for healthcare workers in South Korea at the end of February 2021. This study investigated severe acute respiratory …
Abstract Background and Objectives Healthcare workers (HCWs) were among the first groups to be vaccinated in Turkey. The data to be obtained by the vaccination of HCWs …
Y Che, X Liu, Y Pu, M Zhou, Z Zhao… - … diseases: an official …, 2020 - ncbi.nlm.nih.gov
Background We evaluated an inactivated SARS-CoV-2 vaccine for immunogenicity and safety in adults aged 18-59 years. Methods In this randomized, double-blinded and …
C Cucunawangsih, RS Wijaya, NPH Lugito… - International Journal of …, 2021 - Elsevier
ABSTRACT Background As healthcare workers (HCWs) are at high risk for infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), they have priority for …
J Herzberg, T Vollmer, B Fischer, H Becher, AK Becker… - Vaccine, 2022 - Elsevier
Background Following a year of development, several vaccines have been approved to contain the global COVID-19 pandemic. Real world comparative data on immune response …
H Kusunoki, M Ohkusa, R Iida, A Saito, M Kawahara… - Vaccines, 2023 - mdpi.com
Objective: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody titers level and duration of elevated levels are considered important indicators for confirming the …
R Levi, E Azzolini, C Pozzi, L Ubaldi… - The Journal of …, 2021 - Am Soc Clin Investig
BACKGROUND The COVID-19 vaccines currently in use require 2 doses to achieve optimal protection. Currently, there is no indication as to whether individuals who have been …